Differential response to treatment of relapsing–remitting multiple sclerosis with IFN-β: is there a dichotomy into T-helper-1 and -17 driven disease?

  • Robert Weissert
  • Future Neurology, July 2010, Future Medicine
  • DOI: 10.2217/fnl.10.32

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2217/fnl.10.32

The following have contributed to this page: Professor Robert Weissert